The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
Collaboration streamlines patient access to oncology clinical trials
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The workshop was conducted as a part of the NITI–State workshop series
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Subscribe To Our Newsletter & Stay Updated
